The clinical impact of acute vasoreactivity testing in patients with severe pulmonary hypertension associated with lung disease: A retrospective exploratory analysis
The PVR response to NO testing associated with short-term efficacy of pulmonary vasodilators in patients with severe LD-PH. Prospective studies of PVR response to NO testing on the clinical efficacy in large-scale LD-PH cohorts are warranted.
Authors
- Hiroya Hayashi (ORCID: https://orcid.org/0000-0003-3053-0670)
- Akihiro Tsuji (ORCID: https://orcid.org/0000-0002-3280-6119)
- Ryo Takano (ORCID: https://orcid.org/0000-0003-4078-3479)
- Takeshi Ogo
- Tatsuo Aoki
- Takatoyo Kiko (ORCID: https://orcid.org/0000-0003-4298-088X)
- Hiroyuki Endo (ORCID: https://orcid.org/0000-0003-4531-2991)
- Ryotaro Asano (ORCID: https://orcid.org/0000-0003-0303-6546)
- Jin Ueda (ORCID: https://orcid.org/0000-0002-3942-8499)
- Shinya Fujisaki (ORCID: https://orcid.org/0009-0006-4477-2637)
- Naruhiro Nishi
Institutions
- National Cerebral and Cardiovascular Center (JP)
Publication Details
- Journal
- Respiratory Investigation
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1016/j.resinv.2025.02.014
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.52